SLC6A11 and Alzheimer disease: These observations are contrary to our results in an AD model which show that the blockade of GAT3/4 results in reduced tonic inhibition in APPNL-F/NL-F mice in both the CA1 and DG regions, suggesting that GAT3/4 switches from ‘clearing’ excess extracellular GABA, to extruding GABA.